Comments
The National Research Development Corporation (NRDC) has licensed five companies for commercialisation of an anti-diabetes Ayuryedic drug formulation, AYUSH-82, developed by the Central Council for Research in Ayurvedic Science (CCRAS), Minister for Science & Technology Harsh Vardhan informed the Lok Sabha in a written reply on Wednesday.
The five companies that have got the licences are Chaturbhuj Pharamceuticals and LA Grande Herbs & Pharma Ltd in Haridwar, Uttarakhand; Altif Life Science, Baddi, Himachal Pradesh; Dabur India and Kudos Lab, Delhi.
“The licensing of technologies to companies is a source of revenue in terms of lumpsum fee and royalty, which is shared between NRDC and CCRAS,” as per the memorandum of association signed with these companies, the Minister said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.